Randomized trial of therapy with platelet antiaggregants for threatened stroke.
出版信息
Can Med Assoc J. 1980 Feb 9;122(3):293-6.
Abstract
摘要
相似文献
1
Randomized trial of therapy with platelet antiaggregants for threatened stroke.
Can Med Assoc J. 1980 Feb 9;122(3):293-6.
2
Summary of design features: clinical trials of platelet-active drugs in cerebrovascular disease.
Circulation. 1980 Dec;62(6 Pt 2):V88-9.
3
Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
Haematologica. 1980 Jun;65(3):361-9.
4
Trials of antiplatelet drugs: some methodological considerations.
Rev Epidemiol Sante Publique. 1979 Sep 18;27(2):87-90.
5
Prevention of stroke.
Int Anesthesiol Clin. 1984 Fall;22(3):11-29.
6
[Critical approach to a therapeutic trial in secondary prevention of cerebral ischemic accidents by antiaggregants].
Presse Med. 1983 Dec 29;12(48):3045-8.
7
The Canadian trial of aspirin and sulfinpyrazone in threatened stroke.
N Engl J Med. 1978 Oct 26;299(17):953-5. doi: 10.1056/NEJM197810262991714.
8
[Platelet antiaggregants: review of the literature (author's transl)].
Rev Med Brux. 1981 May;2(5):487-92.
9
A randomized trial of aspirin and sulfinpyrazone in threatened stroke.
N Engl J Med. 1978 Jul 13;299(2):53-9. doi: 10.1056/NEJM197807132990201.
10
Does platelet antiaggregant therapy lessen the severity of stroke?
Neurology. 1985 May;35(5):632-6. doi: 10.1212/wnl.35.5.632.
引用本文的文献
1
Plasma salicylate levels and platelet function after acute and chronic administration of slow-release acetylsalicylic acid (Monobeltin).
Eur J Clin Pharmacol. 1985;27(6):683-7. doi: 10.1007/BF00547049.
2
Plasma drug and antiplatelet profiles of the original acetylsalicylic acid preparations used in the AMIS, PARIS and German-Austrian trials for secondary prevention of myocardial infarction.
Eur J Clin Pharmacol. 1988;33(6):541-7. doi: 10.1007/BF00542484.
Zotero 插件